Nonhuman primate models for HIV cure research.
作者信息
Apetrei Cristian, Pandrea Ivona, Mellors John W
机构信息
Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
出版信息
PLoS Pathog. 2012;8(8):e1002892. doi: 10.1371/journal.ppat.1002892. Epub 2012 Aug 30.
Abstract
摘要
相似文献
1
Nonhuman primate models for HIV cure research.
PLoS Pathog. 2012;8(8):e1002892. doi: 10.1371/journal.ppat.1002892. Epub 2012 Aug 30.
2
The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
AIDS Res Hum Retroviruses. 2012 Jan;28(1):16-35. doi: 10.1089/aid.2011.0234. Epub 2011 Oct 19.
3
AIDS vaccine models: challenging challenge viruses.
Nat Med. 2002 Mar;8(3):207-10. doi: 10.1038/nm0302-207.
4
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections.
Cell Host Microbe. 2019 Jul 10;26(1):73-85.e4. doi: 10.1016/j.chom.2019.06.005.
5
Update on animal models for HIV research.
Eur J Immunol. 2009 Aug;39(8):1994-9. doi: 10.1002/eji.200939576.
6
25 years of HIV research! ... and what about a vaccine?
Eur J Immunol. 2009 Aug;39(8):1999-2003. doi: 10.1002/eji.200939551.
7
The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.00226-18. Print 2018 Jul 15.
8
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
J Virol. 2016 May 12;90(11):5315-5328. doi: 10.1128/JVI.00230-16. Print 2016 Jun 1.
9
Drug flushes out hidden AIDS virus.
Science. 2015 Mar 6;347(6226):1056. doi: 10.1126/science.347.6226.1056-a.
10
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S5-32. doi: 10.1586/14760584.3.4.s5.
引用本文的文献
1
So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.
Viruses. 2022 Jan 12;14(1):135. doi: 10.3390/v14010135.
2
Humanized Mice for the Evaluation of Novel HIV-1 Therapies.
Front Immunol. 2021 Apr 1;12:636775. doi: 10.3389/fimmu.2021.636775. eCollection 2021.
3
Insight into treatment of HIV infection from viral dynamics models.
Immunol Rev. 2018 Sep;285(1):9-25. doi: 10.1111/imr.12698.
4
Translational Research in the Nonhuman Primate Model of Tuberculosis.
ILAR J. 2017 Dec 1;58(2):151-159. doi: 10.1093/ilar/ilx015.
5
Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers.
PLoS Pathog. 2016 Sep 15;12(9):e1005879. doi: 10.1371/journal.ppat.1005879. eCollection 2016 Sep.
6
Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.
J Clin Invest. 2016 May 2;126(5):1630-9. doi: 10.1172/JCI85339.
7
Animal Models for HIV Cure Research.
Front Immunol. 2016 Jan 28;7:12. doi: 10.3389/fimmu.2016.00012. eCollection 2016.
8
Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research.
J Virol. 2015 Jun;89(11):6155-60. doi: 10.1128/JVI.00256-15. Epub 2015 Apr 1.
9
Simple mathematical models do not accurately predict early SIV dynamics.
Viruses. 2015 Mar 13;7(3):1189-217. doi: 10.3390/v7031189.
10
Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.
Curr HIV/AIDS Rep. 2015 Mar;12(1):54-67. doi: 10.1007/s11904-014-0245-5.
本文引用的文献
1
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.
PLoS Pathog. 2012;8(6):e1002774. doi: 10.1371/journal.ppat.1002774. Epub 2012 Jun 21.
2
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques.
J Clin Invest. 2012 May;122(5):1712-6. doi: 10.1172/JCI60612. Epub 2012 Apr 23.
3
HIV prevention by oral preexposure prophylaxis.
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007419. doi: 10.1101/cshperspect.a007419.
4
New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyond.
Curr HIV/AIDS Rep. 2012 Mar;9(1):91-100. doi: 10.1007/s11904-011-0104-6.
5
Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.
Curr HIV Res. 2011 Dec 1;9(8):568-78. doi: 10.2174/157016211798998826.
6
Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells.
PLoS Pathog. 2011 Oct;7(10):e1002288. doi: 10.1371/journal.ppat.1002288. Epub 2011 Oct 6.
7
New paradigms for HIV/AIDS vaccine development.
Annu Rev Med. 2012;63:95-111. doi: 10.1146/annurev-med-042010-085643. Epub 2011 Sep 19.
8
The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
AIDS Res Hum Retroviruses. 2012 Jan;28(1):16-35. doi: 10.1089/aid.2011.0234. Epub 2011 Oct 19.
9
Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion.
PLoS Pathog. 2011 Aug;7(8):e1002170. doi: 10.1371/journal.ppat.1002170. Epub 2011 Aug 4.
10
Simian immunodeficiency virus macaque models of HIV latency.
Curr Opin HIV AIDS. 2011 Jan;6(1):57-61. doi: 10.1097/COH.0b013e32834086ce.
Zotero 插件